These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 29180645)

  • 1. Combinations of chromosome transfer and genome editing for the development of cell/animal models of human disease and humanized animal models.
    Uno N; Abe S; Oshimura M; Kazuki Y
    J Hum Genet; 2018 Feb; 63(2):145-156. PubMed ID: 29180645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Humanized UGT2 and CYP3A transchromosomic rats for improved prediction of human drug metabolism.
    Kazuki Y; Kobayashi K; Hirabayashi M; Abe S; Kajitani N; Kazuki K; Takehara S; Takiguchi M; Satoh D; Kuze J; Sakuma T; Kaneko T; Mashimo T; Osamura M; Hashimoto M; Wakatsuki R; Hirashima R; Fujiwara R; Deguchi T; Kurihara A; Tsukazaki Y; Senda N; Yamamoto T; Scheer N; Oshimura M
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):3072-3081. PubMed ID: 30718425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome editing for the reproduction and remedy of human diseases in mice.
    Hara S; Takada S
    J Hum Genet; 2018 Feb; 63(2):107-113. PubMed ID: 29180644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transchromosomic technology for genomically humanized animals.
    Moriwaki T; Abe S; Oshimura M; Kazuki Y
    Exp Cell Res; 2020 May; 390(2):111914. PubMed ID: 32142854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Humanized Mice in the Age of Genome Editing.
    Hosur V; Low BE; Avery C; Shultz LD; Wiles MV
    J Cell Biochem; 2017 Oct; 118(10):3043-3048. PubMed ID: 28332231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of genome editing technologies in rats for human disease models.
    Yoshimi K; Mashimo T
    J Hum Genet; 2018 Feb; 63(2):115-123. PubMed ID: 29158599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modification of single-nucleotide polymorphism in a fully humanized CYP3A mouse by genome editing technology.
    Abe S; Kobayashi K; Oji A; Sakuma T; Kazuki K; Takehara S; Nakamura K; Okada A; Tsukazaki Y; Senda N; Honma K; Yamamoto T; Ikawa M; Chiba K; Oshimura M; Kazuki Y
    Sci Rep; 2017 Nov; 7(1):15189. PubMed ID: 29123154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Progress in Therapeutic Gene Editing for Monogenic Diseases.
    Prakash V; Moore M; Yáñez-Muñoz RJ
    Mol Ther; 2016 Mar; 24(3):465-74. PubMed ID: 26765770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse embryonic stem cells with a multi-integrase mouse artificial chromosome for transchromosomic mouse generation.
    Yoshimura Y; Nakamura K; Endo T; Kajitani N; Kazuki K; Kazuki Y; Kugoh H; Oshimura M; Ohbayashi T
    Transgenic Res; 2015 Aug; 24(4):717-27. PubMed ID: 26055730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
    Zhang X; Wang L; Liu M; Li D
    Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome Editing of Structural Variations: Modeling and Gene Correction.
    Park CY; Sung JJ; Kim DW
    Trends Biotechnol; 2016 Jul; 34(7):548-561. PubMed ID: 27016031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the Genome of Domestic Animals.
    Lotti SN; Polkoff KM; Rubessa M; Wheeler MB
    Anim Biotechnol; 2017 Jul; 28(3):198-210. PubMed ID: 28103141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of CRISPR/Cas9 Genome Editing to Improve Recombinant Protein Production in CHO Cells.
    Grav LM; la Cour Karottki KJ; Lee JS; Kildegaard HF
    Methods Mol Biol; 2017; 1603():101-118. PubMed ID: 28493126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rabbit models for biomedical research revisited via genome editing approaches.
    Honda A; Ogura A
    J Reprod Dev; 2017 Oct; 63(5):435-438. PubMed ID: 28579598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple, Efficient CRISPR-Cas9-Mediated Gene Editing in Mice: Strategies and Methods.
    Low BE; Kutny PM; Wiles MV
    Methods Mol Biol; 2016; 1438():19-53. PubMed ID: 27150082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel transchromosomic system: stable maintenance of an engineered Mb-sized human genomic fragment translocated to a mouse chromosome terminal region.
    Takehara S; Schulz TC; Abe S; Takiguchi M; Kazuki K; Kishigami S; Wakayama T; Tomizuka K; Oshimura M; Kazuki Y
    Transgenic Res; 2014 Jun; 23(3):441-53. PubMed ID: 24488595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanising the mouse genome piece by piece.
    Zhu F; Nair RR; Fisher EMC; Cunningham TJ
    Nat Commun; 2019 Apr; 10(1):1845. PubMed ID: 31015419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model.
    Wu W; Lu Z; Li F; Wang W; Qian N; Duan J; Zhang Y; Wang F; Chen T
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1660-1665. PubMed ID: 28137859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid human genomic DNA cloning into mouse artificial chromosome via direct chromosome transfer from human iPSC and CRISPR/Cas9-mediated translocation.
    Miyamoto H; Kobayashi H; Kishima N; Yamazaki K; Hamamichi S; Uno N; Abe S; Hiramuki Y; Kazuki K; Tomizuka K; Kazuki Y
    Nucleic Acids Res; 2024 Feb; 52(3):1498-1511. PubMed ID: 38180813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9-mediated correction of human genetic disease.
    Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
    Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.